Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022
- ALL385415
- 235 Pages
- December 2016
- Diagnostic and Biotech
In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The Asia Pacific IVF services market, valued at $3.0 billion in 2015, is estimated to reach $7.1 billion by 2022. Delayed pregnancy in women is one of the major driving factors of the embryo transfer market, as the chances of conceiving lowers with age. Success rate of getting pregnant with embryo transfer technique reduces with increase in age. Other driving factors of the embryo transfer market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, around 15% of the couples faces infertility issues in which males contribute to 20-30% of the overall cases.
The major limiting factors of this market are the cost involved and lower success rates in the treatment. Patients may not conceive in the first cycle of embryo transfer procedure. Patients have to undergo many cycles to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $3,000- $8,000. This acts as a major limitation, in adoption of the technique, for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria, India, Indonesia among others. Awareness can be created through medical tourism and availability of low cost embryo transfer treatments. The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Fisher Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ovascience Inc.
KEY BENEFITS FOR STAKEHOLDERS:
- This report provides an in-depth analysis of the Asia-Pacific IVF market across twelve major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
- The report includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market.
- This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region.
- The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022.
- Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.
KEY MARKET SEGMENTS:
By End Users (Value and Volume)
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
By Cycle Type, (Value and Volume)
- Fresh Cycle (Non-Donor)
- Thawed IVF Cycle (Non-Donor)
- Donor Egg IVF Cycles
By Cycle Type Country Level Analysis (Value and Volume)
- India
- China
- Japan
- Australia
- New Zealand
- Korea
- Thailand
- Singapore
- Malaysia
- Indonesia
- Philippines
- Vietnam
- Rest of Asia-Pacific
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Coverage and limitations
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 ASIA-PACIFIC IVF MARKET ANALYSIS
3.1 Market definition and scope
3.2 Overview
3.3 Drivers
3.3.1 Delay in family planning reduces chances of conception
3.3.2 Decline in birth rate
3.3.3 Emotional problems
3.4 Restraints
3.5 Asia-Pacific embryo transfer market, by Country
3.6 Asia-Pacific embryo transfer market by Cycle Types
3.7 Asia-Pacific embryo transfer market by End Users
3.8 Company Profile
3.8.1 Thermo Fisher Scientific, Inc.
3.8.2 Merck KGaA
CHAPTER 4 INDIA EMBRYO TRANSFER MARKET
4.1 Overview
4.2 India Embryo Transfer Market by End Users
4.2.1 Fertility clinics
4.2.2 Hospitals
4.2.3 Surgical centers
4.2.4 Clinical research institutes
4.3 India IVF Market by Cycle Type
4.3.1 Fresh IVF cycles (non-donor)
4.3.2 Thawed IVF cycles (non-donor)
4.3.3 Donor egg IVF cycles
4.4 Drivers
4.5 Restraints
4.6 Regulatory issues, legislations, and authorities
4.7 Insurance reimbursement scenario
4.8 Company/Hospitals/Clinics Profile
4.8.1 Sun Pharmaceutical Industries Ltd.
4.8.2 Trivector Origio Scientific Pvt. Ltd
4.8.3 Lab IVF Asia Pte. Ltd.
4.8.4 LG Life Sciences.
4.8.5 Cadila Healthcare Ltd. (Zydus Cadila group)
4.8.6 Bourn Hall Clinic
4.8.7 Morpheus IVF Fertility Center
4.8.8 Southend Fertility and IVF Centre
4.8.9 Nova IVI Fertility
4.8.10 Bloom Fertility Center
4.8.11 Manipal Ankur
4.8.12 Cloudnine
CHAPTER 5 CHINA EMBRYO TRANSFER MARKET
5.1 Overview
5.2 China Embryo Transfer Market by End Users
5.2.1 Fertility clinics
5.2.2 Hospitals
5.2.3 Surgical centers
5.2.4 Clinical research institutes
5.3 China IVF Market by Cycle Type
5.3.1 Fresh IVF cycles (non-donor)
5.3.2 Thawed IVF cycles (non-donor)
5.3.3 Donor egg IVF cycles
5.4 Drivers
5.4.1 Increased rate of infertility
5.4.2 Change in lifestyle
5.5 Restraints
5.5.1 Cost of living
5.6 Regulatory issues, legislations, and authorities
5.7 Insurance reimbursement scenario
5.8 Company/Hospitals/Clinics Profile
5.8.1 Cook Medical, Inc.
5.8.2 Vitrolife AB
5.8.3 Centre for Reproductive Medicine
5.8.4 Reproductive & Genetic Hospital Citic-Xiangya
5.8.5 Shenyang International Hospital
5.8.6 Shandong Provincial Hospital
CHAPTER 6 JAPAN EMBRYO TRANSFER MARKET
6.1 Overview
6.2 Japan Embryo Transfer Market by End Users
6.2.1 Fertility clinics
6.2.2 Hospitals
6.2.3 Surgical centers
6.2.4 Clinical research institutes
6.3 Japan IVF Market by Cycle Type
6.3.1 Fresh IVF cycles (non-donor)
6.3.2 Thawed IVF cycles (non-donor)
6.4 Drivers
6.5 Restraints
6.6 Regulatory issues, legislations, and authorities
6.7 Insurance reimbursement scenario
6.8 Company/Hospitals/Clinics Profile
6.8.1 Merck KGaA
6.8.2 IVF Namba Clinic
6.8.3 Iwaki Womens Clinic
6.8.4 Sanno Hospital
CHAPTER 7 AUSTRALIA EMBRYO TRANSFER MARKET
7.1 Overview
7.2 Australia Embryo Transfer Market by End Users
7.2.1 Fertility clinics
7.2.2 Hospitals
7.2.3 Surgical centers
7.2.4 Clinical research institutes
7.3 Australia IVF Market by Cycle Type
7.3.1 Fresh IVF cycles (non-donor)
7.3.2 Thawed IVF cycles (non-donor)
7.4 Drivers
7.5 Restraints
7.5.1 Emotional and physical stress
7.5.2 No guarantee
7.5.3 Surplus embryos
7.6 Regulatory issues, legislations, and authorities
7.6.1 Common Law
7.6.2 Legislative responses to IVF
7.6.3 Non-legislative regulation for the practice of IVF
7.7 Insurance reimbursement scenario
7.8 Company/Hospitals/Clinics Profile
7.8.1 Genea Biomedx
7.8.2 Thermo Fisher Scientific, Inc.
7.8.3 Virtus Health
7.8.4 Monash IVF
7.8.5 City Fertility
7.8.6 Flinders Fertility
CHAPTER 8 NEW ZEALAND EMBRYO TRANSFER MARKET
8.1 Overview
8.2 New Zealand Embryo Transfer Market by End Users
8.2.1 Fertility clinics
8.2.2 Hospitals
8.2.3 Surgical centers
8.2.4 Clinical research institutes
8.3 New Zealand IVF Market by Cycle Type
8.3.1 Fresh IVF cycles (non-donor)
8.3.2 Thawed IVF cycles (non-donor)
8.3.3 Donor egg IVF cycles
8.4 Drivers
8.5 Restraints
8.6 Regulatory issues, legislations, and authorities
8.7 Insurance reimbursement scenario
8.8 Hospitals/Clinics Profile
8.8.1 Fertility Associates
8.8.2 Fertility Plus
8.8.3 Reporomed
CHAPTER 9 KOREA EMBRYO TRANSFER MARKET
9.1 Overview
9.2 Korea Embryo Transfer Market by End Users
9.2.1 Fertility clinics
9.2.2 Hospitals
9.2.3 Surgical centers
9.2.4 Clinical research institutes
9.3 Korea IVF Market by Cycle Type
9.3.1 Fresh IVF cycles (non-donor)
9.3.2 Thawed IVF cycles (non-donor)
9.3.3 Donor egg IVF cycles
9.4 Drivers
9.5 Restraints
9.6 Regulatory issues, legislations, and authorities
9.7 Insurance reimbursement scenario
9.8 Hospitals/Clinics Profile
9.8.1 Cha General Hospital
9.8.2 Maria Fertility Hospital
CHAPTER 10 THAILAND EMBRYO TRANSFER MARKET
10.1 Overview
10.2 Thailand Embryo Transfer Market by End Users
10.2.1 Fertility clinics
10.2.2 Hospitals
10.2.3 Surgical centers
10.2.4 Clinical research institutes
10.3 Thailand IVF Market by Cycle Type
10.3.1 Fresh IVF cycles (non-donor)
10.3.2 Thawed IVF cycles (non-donor)
10.3.3 Donor egg IVF cycles
10.4 Drivers
10.4.1 Government initiatives
10.4.2 Surrogacy is economical as compared to developed countries
10.4.3 Boost in medical tourism
10.5 Restraints
10.5.1 Comparatively low success rate
10.5.2 Ethical issues in allowing gender selection
10.6 Regulatory issues, legislations, and authorities
10.7 Insurance reimbursement scenario
10.8 Hospitals/Clinics Profile
10.8.1 Bangkok Fertility Center
10.8.2 Siriraj Hospital
10.8.3 Ramathibodi Hospital
10.8.4 Perfect Woman Institute Piyavate Hospital
10.8.5 Jetanin Institute for Assisted Reproduction
CHAPTER 11 SINGAPORE EMBRYO TRANSFER MARKET
11.1 Overview
11.2 Singapore Embryo Transfer Market by End Users
11.2.1 Fertility clinics
11.2.2 Hospitals
11.2.3 Surgical centers
11.2.4 Clinical research institutes
11.3 Singapore IVF Market by Cycle Type
11.3.1 Fresh IVF cycles (non-donor)
11.3.2 Thawed IVF cycles (non-donor)
11.4 Drivers
11.4.1 Government funding and tax rebates for parents
11.4.2 Rising infertility rate
11.4.3 Increase in success rate
11.5 Restraints
11.5.1 High cost of IVF treatment and lower success rate
11.6 Regulatory issues, legislations, and authorities
11.7 Insurance reimbursement scenario
11.8 Company/Clinics Profile
11.8.1 Irvine Scientific
11.8.2 ESCO Technologies Inc.
11.8.3 Leica Microsystems GMBH
11.8.4 NUH IVF Centre
11.8.5 Mount Elizabeth Fertility Center
11.8.6 Thomson Fertility Centre
11.8.7 Raffles Fertility Centre
CHAPTER 12 MALAYSIAN EMBRYO TRANSFER MARKET
12.1 Overview
12.2 Malaysia Embryo Transfer Market by End Users
12.2.1 Fertility clinics
12.2.2 Hospitals
12.2.3 Surgical centers
12.2.4 Clinical research institutes
12.3 Malaysia IVF Market by Cycle Type
12.3.1 Fresh IVF cycles (non-donor)
12.3.2 Thawed IVF cycles (non-donor)
12.3.3 Donor egg IVF cycles
12.4 Drivers
12.4.1 Increase in government initiatives
12.4.2 Increase in the number of foreign patients
12.4.3 Decrease in rate of fertility and growing acceptability of IVF
12.5 Restraints
12.6 Regulatory issues, legislations, and authorities
12.7 Insurance reimbursement scenario
12.8 Clinics Profile
12.8.1 Subang Fertility Center
12.8.2 Concept Fertility Centre
12.8.3 TMC Fertility Center
CHAPTER 13 INDONESIAN EMBRYO TRANSFER MARKET
13.1 Overview
13.2 Indonesia Embryo Transfer Market by End Users
13.2.1 Fertility clinics
13.2.2 Hospitals
13.2.3 Surgical centers
13.2.4 Clinical research institutes
13.3 Indonesia IVF Market by Cycle Type
13.3.1 Fresh IVF cycles (non-donor)
13.3.2 Thawed IVF cycles (non-donor)
13.3.3 Donor egg IVF cycles
13.4 Drivers
13.4.1 Increase in disposable income
13.4.2 Advances in embryo transfer technology
13.4.3 Decline in fertility rate
13.5 Restraints
13.5.1 Physical and emotional impact due to low success rate
13.6 Regulatory issues, legislations, and authorities
13.7 Insurance reimbursement scenario
13.8 Clinics Profile
13.8.1 Morula IVF
13.8.2 Yasmin IVF
13.8.3 Aster Fertility Clinic
13.8.4 Fertility Centre, Siloam Hospitals Surabana
CHAPTER 14 PHILIPPINES EMBRYO TRANSFER MARKET
14.1 Overview
14.2 Philippines Embryo Transfer Market by End Users
14.2.1 Fertility clinics
14.2.2 Hospitals
14.2.3 Surgical centers
14.2.4 Clinical research institutes
14.3 Philippines IVF market by cycle type
14.3.1 Fresh IVF cycles (non-donor)
14.3.2 Thawed IVF cycles (non-donor)
14.3.3 Donor egg IVF cycles
14.4 Drivers
14.4.1 Improve the replacement population
14.4.2 Advancement in technology
14.5 Restraints
14.6 Regulatory issues, legislations, and authorities
14.7 Insurance reimbursement scenario
14.8 Clinic Profile
14.8.1 Victory Art Lab
14.8.2 CRM-MIA-Philippines
CHAPTER 15 VIETNAM EMBRYO TRANSFER MARKET
15.1 Overview
15.2 Vietnam Embryo Transfer Market by End Users
15.2.1 Fertility clinics
15.2.2 Hospitals
15.2.3 Surgical centers
15.2.4 Clinical research institutes
15.3 Vietnam IVF market by cycle type
15.3.1 Fresh IVF cycles (non-donor)
15.3.2 Thawed IVF cycles (non-donor)
15.3.3 Donor egg IVF cycles
15.4 Drivers
15.4.1 Decline in fertility rate
15.4.2 Reasonable cost and good success rate
15.5 Restraints
15.6 Regulatory issues, legislations, and authorities
15.7 Insurance reimbursement scenario
15.8 Hospital/Clinic Profile
15.8.1 IVF Lab Tu Du Hospital Vietnam
15.8.2 IVF Van Hanh
15.8.3 Sinh Hospital
15.8.4 Tu Du - Ho Chi Minh City Vietnam
CHAPTER 16 REST OF ASIA-PACIFIC EMBRYO TRANSFER MARKET
16.1 Overview
16.2 Rest of Asia-Pacific Embryo Transfer Market by End Users
16.2.1 Fertility clinics
16.2.2 Hospitals
16.2.3 Surgical centers
16.2.4 Clinical research institutes
16.3 Rest of Asia-Pacific IVF Market by Cycle Type
16.3.1 Fresh IVF cycles (non-donor)
16.3.2 Thawed IVF cycles (non-donor)
16.3.3 Donor egg IVF cycles
16.4 Drivers
16.4.1 Increase in disposable income
16.4.2 Advances in IVF technology
16.4.3 Decline in fertility rate
16.5 Restraints
16.5.1 Physical and emotional impact due to low success rate
16.6 Regulatory Issues, legislations, and Authorities
16.7 Insurance Reimbursement Scenario
16.8 Hospitals/Clinics Profile
16.8.1 Fertility Centre, Siloam Hospitals Surabana
16.8.2 CRM-MIA-Philippines
16.8.3 IVFAS
List of Figures
FIG. 1 PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY FACTORS (SINGAPORE, THAILAND, INDONESIA, AND CHINA)
FIG. 2 INDIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIG. 3 INDIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 4 INDIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 5 INDIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 6 INDIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 7 INDIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 8 INDIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 9 INDIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 10 CHINA FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
FIG. 11 CHINA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 12 CHINA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 13 CHINA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 14 CHINA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 15 CHINA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 16 CHINA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 17 CHINA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 18 JAPAN: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
FIG. 19 JAPAN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 20 JAPAN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 21 JAPAN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 22 JAPAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 23 JAPAN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 24 JAPAN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 25 AUSTRALIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIG. 26 IVF SUCCESS RATE FOR AUSTRALIA
FIG. 27 AUSTRALIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 28 AUSTRALIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 29 AUSTRALIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 30 AUSTRALIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 31 AUSTRALIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 32 AUSTRALIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 33 NEW ZEALAND TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
FIG. 34 NEW ZEALAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 35 NEW ZEALAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 36 NEW ZEALAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 37 NEW ZEALAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 38 NEW ZEALAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 39 NEW ZEALAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 40 NEW ZEALAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 41 SOUTH KOREA TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
FIG. 42 KOREA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 43 KOREA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 44 KOREA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 45 KOREA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 46 KOREA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 47 KOREA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 48 KOREA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 49 THAILAND FERTILITY RATE CHILD BORN/WOMEN (2014-2020)
FIG. 50 THAILAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 51 THAILAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 52 THAILAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 53 THAILAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 54 THAILAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 55 THAILAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 56 THAILAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 57 SINGAPORE: FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIG. 58 SINGAPORE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 59 SINGAPORE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 60 SINGAPORE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 61 SINGAPORE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 62 SINGAPORE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 63 SINGAPORE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 64 MALAYSIA: FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIG. 65 MALAYSIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 66 MALAYSIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 67 MALAYSIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 68 MALAYSIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 69 MALAYSIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 70 MALAYSIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 71 MALAYSIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 72 INDONESIAN FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIG. 73 INDONESIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 74 INDONESIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 75 INDONESIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 76 INDONESIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 77 INDONESIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 78 INDONESIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 79 INDONESIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 80 PHILIPPINES FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIG. 81 PHILIPPINES IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 82 PHILIPPINES IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 83 PHILIPPINES IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 84 PHILIPPINES IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 85 PHILIPPINES IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 86 PHILIPPINES IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 87 PHILIPPINES IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 88 VIETNAM FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
FIG. 89 VIETNAM IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 90 VIETNAM IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 91 VIETNAM IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 92 VIETNAM IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 93 VIETNAM IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 94 VIETNAM IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 95 VIETNAM IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 96 REST OF ASIA-PACIFIC IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 97 REST OF ASIA-PACIFIC IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 98 REST OF ASIA-PACIFIC IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 99 REST OF ASIA-PACIFIC IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 100 REST OF ASIA-PACIFIC IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 101 REST OF ASIA-PACIFIC IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIG. 102 REST OF ASIA-PACIFIC IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
List of Tables
TABLE 1 ASIA-PACIFIC IVF CYCLES MARKET VOLUME, BY COUNTRY, 2014-2022(THOUSAND)
TABLE 2 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY COUNTRY, 2014-2022($MILLION)
TABLE 3 ASIA-PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 4 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 5 ASIA-PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY END USER, 2015-2022 (THOUSAND)
TABLE 6 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY END USER, 2015-2022 ($MILLION)
TABLE 7 THERMO FISHER SCIENTIFIC, INC., BUSINESS OVERVIEW
TABLE 8 COMPANY SNAPSHOT
TABLE 9 MERCK KGAA: BUSINESS OVERVIEW
TABLE 10 COMPANY SNAPSHOT
TABLE 11 INDIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 12 INDIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 13 INDIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 14 INDIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 15 INDIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 16 SUN PHARMACEUTICAL BUSINESS OVERVIEW
TABLE 17 COMPANY SNAPSHOT
TABLE 18 TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEW
TABLE 19 COMPANY SNAPSHOT
TABLE 20 LAB IVF ASIA BUSINESS OVERVIEW
TABLE 21 COMPANY SNAPSHOT
TABLE 22 LG LIFE SCIENCE BUSINESS OVERVIEW
TABLE 23 COMPANY SNAPSHOT
TABLE 24 CADILA HEALTH CARE BUSINESS OVERVIEW
TABLE 25 COMPANY SNAPSHOT
TABLE 26 CHINA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 27 CHINA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 28 CHINA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 29 CHINA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 30 CHINA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 31 COOK MEDICAL, INC. BUSINESS OVERVIEW
TABLE 32 COMPANY SNAPSHOT
TABLE 33 VITROLIFE AB, INC. BUSINESS OVERVIEW
TABLE 34 COMPANY SNAPSHOT
TABLE 35 JAPAN IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 36 JAPAN IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 37 JAPAN IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 38 JAPAN IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 39 JAPAN IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 40 EMD SERONO INC BUSINESS OVERVIEW
TABLE 41 COMPANY SNAPSHOT
TABLE 42 AUSTRALIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 43 OUTCOMES OF CYCLES OF IVF BY WOMENS AGE GROUP, 2011
TABLE 44 AUSTRALIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 45 AUSTRALIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 46 AUSTRALIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 47 AUSTRALIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 48 GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
TABLE 49 COMPANY SNAPSHOT
TABLE 50 THERMO FISHER SCIENTIFIC INC BUSINESS OVERVIEW
TABLE 51 COMPANY SNAPSHOT
TABLE 52 NEW ZEALAND IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 53 NEW ZEALAND IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 54 NEW ZEALAND IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 55 NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 56 NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 57 KOREA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 58 KOREA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 59 KOREA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 60 KOREA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 61 KOREA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 62 THAILAND IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 63 THAILAND IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 64 THAILAND IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 65 THAILAND IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 66 THAILAND IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 67 SINGAPORE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 68 SINGAPORE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 69 SINGAPORE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 70 SINGAPORE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 71 SINGAPORE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 72 IRVINE SCIENTIFIC BUSINESS OVERVIEW
TABLE 73 COMPANY SNAPSHOT
TABLE 74 ESCO TECHNOLOGIES BUSINESS OVERVIEW
TABLE 75 COMPANY SNAPSHOT
TABLE 76 LEICA MICROSYSTEMS GMBH BUSINESS OVERVIEW
TABLE 77 COMPANY SNAPSHOT
TABLE 78 MALAYSIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 79 MALAYSIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 80 MALAYSIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 81 MALAYSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 82 MALAYSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 83 INDONESIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 84 INDONESIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 85 INDONESIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 86 INDONESIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 87 INDONESIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 88 PHILIPPINES IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 89 PHILIPPINES IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 90 PHILIPPINES IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 91 PHILIPPINES IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 92 PHILIPPINES IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 93 VIETNAM IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 94 VIETNAM IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 95 VIETNAM IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 96 VIETNAM IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 97 VIETNAM IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 98 REST OF ASIA-PACIFIC IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 99 REST OF ASIA-PACIFIC IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 100 REST OF ASIA-PACIFIC IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
TABLE 101 REST OF ASIA-PACIFIC IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 102 REST OF ASIA-PACIFIC IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 103 EMBRYO TRANSFER COST PER CYCLE BY COUNTRY (2014)
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
